Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, as the pharmaceutical company expands its ...

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, expanding its immunology pipeline ...

The FDA plans to roll out its agency-wide AI tool weeks ahead of schedule, per a press release that provides the most ...

Two companies trying to develop psychedelic medicines make a merger deal as the Trump administration has expressed support ...

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

An experimental medicine from Vera Therapeutics significantly reduced levels of toxic protein in the urine of patients with ...

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

ASCO heard data suggesting that cell therapy may be a way of treating glioblastoma, which has been long seen as incurable.

The relentless drumbeat of cuts to U.S. government research and disease prevention have devastated tens of thousands of ...

In a new interview, the FDA commissioner had few answers on how Americans should think about Covid vaccines. Instead, he ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...